Loading...
SNDL Inc.
SNDL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.51
$-0.03(-1.62%)
SNDL Inc. (SNDL) Financial Performance & Income Statement Overview
Review SNDL Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.26%
↑ 1.26%
Operating Income Growth
36.38%
↑ 36.38%
Net Income Growth
45.10%
↑ 45.10%
Operating Cash Flow Growth
429.85%
↑ 429.85%
Operating Margin
-12.02%
↓ 12.02%
Gross Margin
26.58%
↑ 26.58%
Net Profit Margin
-11.53%
↓ 11.53%
ROE
-9.16%
↓ 9.16%
ROIC
-9.13%
↓ 9.13%
SNDL Inc. (SNDL) Income Statement & Financial Overview
Review SNDL Inc.'s (SNDL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $257.68M | $236.89M | $228.13M | $197.75M |
| Cost of Revenue | $188.88M | $173.92M | $169.96M | $147.35M |
| Gross Profit | $68.80M | $62.97M | $58.16M | $50.40M |
| Gross Profit Ratio | $0.27 | $0.27 | $0.25 | $0.25 |
| R&D Expenses | $124000.00 | $76000.00 | $109000.00 | $37000.00 |
| SG&A Expenses | $52.30M | $58.49M | $56.36M | $52.14M |
| Operating Expenses | $144.89M | $81.48M | $69.99M | $66.32M |
| Total Costs & Expenses | $333.77M | $255.40M | $232.96M | $213.67M |
| Interest Income | $15.82M | $194000.00 | $3.41M | $4.29M |
| Interest Expense | $1.91M | $1.90M | $1.93M | $1.95M |
| Depreciation & Amortization | $14.03M | $13.97M | $14.14M | $14.57M |
| EBITDA | -$57.87M | -$2.03M | $9.82M | $8.88M |
| EBITDA Ratio | -$0.22 | -$0.009 | $0.04 | $0.04 |
| Operating Income | -$76.09M | -$18.51M | -$4.83M | -$4.38M |
| Operating Income Ratio | -$0.30 | -$0.08 | -$0.02 | -$0.02 |
| Other Income/Expenses (Net) | $2.28M | $609000.00 | -$1.42M | -$3.27M |
| Income Before Tax | -$73.81M | -$17.90M | -$6.25M | -$7.65M |
| Income Before Tax Ratio | -$0.29 | -$0.08 | -$0.03 | -$0.04 |
| Income Tax Expense | -$6.56M | $1.43M | -$1.28M | -$3.00M |
| Net Income | -$67.14M | -$19.33M | -$5.77M | -$2.55M |
| Net Income Ratio | -$0.26 | -$0.08 | -$0.03 | -$0.01 |
| EPS | -$0.25 | -$0.07 | -$0.02 | -$0.010 |
| Diluted EPS | -$0.25 | -$0.07 | -$0.02 | -$0.010 |
| Weighted Avg Shares Outstanding | $265.15M | $265.15M | $263.84M | $262.97M |
| Weighted Avg Shares Outstanding (Diluted) | $265.15M | $265.15M | $263.83M | $262.97M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan